|
1
|
Hariharan D, Saied A and Kocher HM:
Analysis of mortality rates for pancreatic cancer across the world.
HPB (Oxford). 10:58–62. 2008. View Article : Google Scholar
|
|
2
|
Decker GA, Batheja MJ, Collins JM, et al:
Risk factors for pancreatic adenocarcinoma and prospects for
screening. Gastroenterol Hepatol (NY). 6:246–254. 2010.
|
|
3
|
Shain AH, Giacomini CP, Matsukuma K, et
al: Convergent structural alterations define SWItch/Sucrose
NonFermentable (SWI/SNF) chromatin remodeler as a central tumor
suppressive complex in pancreatic cancer. Proc Natl Acad Sci USA.
109:E252–E259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jones S, Zhang X, Parsons DW, et al: Core
signaling pathways in human pancreatic cancers revealed by global
genomic analyses. Science. 321:1801–1806. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Efthimiou E, Crnogorac-Jurcevic T, Lemoine
NR and Brentnall TA: Inherited predisposition to pancreatic cancer.
Gut. 48:143–147. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang H: RNAi-mediated knockdown of target
genes: a promising strategy for pancreatic cancer research. Cancer
Gene Ther. 14:677–685. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gartel AL and Kandel ES: RNA interference
in cancer. Biomol Eng. 23:17–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Okamoto K and Murawaki Y: The therapeutic
potential of RNA interference: novel approaches for cancer
treatment. Curr Pharm Biotechnol. 13:2235–2247. 2012. View Article : Google Scholar
|
|
9
|
Zhao X, Zhu DM, Gan WJ, et al:
Lentivirus-mediated shRNA interference targeting vascular
endothelial growth factor inhibits angiogenesis and progression of
human pancreatic carcinoma. Oncol Rep. 29:1019–1026. 2013.
|
|
10
|
Zhu XY, Liu N, Liu W, Song SW and Guo KJ:
Silencing of the integrin-linked kinase gene suppresses the
proliferation, migration and invasion of pancreatic cancer cells
(Panc-1). Genet Mol Biol. 35:538–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li C, Ge M, Yin Y, Luo M and Chen D:
Silencing expression of ribosomal protein L26 and L29 by RNA
interfering inhibits proliferation of human pancreatic cancer
PANC-1 cells. Mol Cell Biochem. 370:127–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hoskins AA and Moore MJ: The spliceosome:
a flexible, reversible macromolecular machine. Trends Biochem Sci.
37:179–188. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Will CL and Luhrmann R: Spliceosome
structure and function. Cold Spring Harb Perspect Biol. 3:pii2011.
View Article : Google Scholar
|
|
14
|
Wahl MC, Will CL and Lührmann R: The
spliceosome: design principles of a dynamic RNP machine. Cell.
136:701–718. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chesnais V, Kosmider O, Damm F, et al:
Spliceosome mutations in myelodysplastic syndromes and chronic
myelomonocytic leukemia. Oncotarget. 3:1284–1293. 2012. View Article : Google Scholar
|
|
16
|
Scott LM and Rebel VI: Acquired mutations
that affect pre-mRNA splicing in hematologic malignancies and solid
tumors. J Natl Cancer Inst. 105:1540–1549. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bonnal S, Vigevani L and Valcárcel J: The
spliceosome as a target of novel antitumour drugs. Nat Rev Drug
Discov. 11:847–859. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cappellari M, Bielli P, Paronetto MP, et
al: The transcriptional co-activator SND1 is a novel regulator of
alternative splicing in prostate cancer cells. Oncogene.
33:3794–3802. 2014. View Article : Google Scholar
|
|
19
|
Quidville V, Alsafadi S, Goubar A, et al:
Targeting the deregulated spliceosome core machinery in cancer
cells triggers mTOR blockade and autophagy. Cancer Res.
73:2247–2258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee SH, Appleby V, Jeyapalan JN, et al:
Variable methylation of the imprinted gene, SNRPN, supports a
relationship between intra-cranial germ cell tumours and neural
stem cells. J Neurooncol. 101:419–428. 2011. View Article : Google Scholar
|
|
21
|
Benetatos L, Hatzimichael E, Dasoula A, et
al: CpG methylation analysis of the MEG3 and SNRPN imprinted genes
in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res.
34:148–153. 2010. View Article : Google Scholar
|
|
22
|
McGarrity GJ, Hoyah G, Winemiller A, et
al: Patient monitoring and follow-up in lentiviral clinical trials.
J Gene Med. 15:78–82. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
D'Costa J, Mansfield SG and Humeau LM:
Lentiviral vectors in clinical trials: Current status. Curr Opin
Mol Ther. 11:554–564. 2009.PubMed/NCBI
|
|
24
|
Fallini C, Bassell GJ and Rossoll W:
Spinal muscular atrophy: the role of SMN in axonal mRNA regulation.
Brain Res. 1462:81–92. 2012. View Article : Google Scholar : PubMed/NCBI
|
